NASDAQ: AIHAesthetic Medical International Holdings Group Ltd Stock
$0.97+0.01 (+1.04%)
Updated Jun 8, 2023
AIH Price
$0.97
Fair Value Price
$1.92
Market Cap
$30.50M
52 Week Low
$0.83
52 Week High
$2.56
P/E
-2.58x
P/B
3.74x
P/S
0.3x
PEG
N/A
Dividend Yield
N/A
Revenue
$94.72M
Earnings
-$10.56M
Gross Margin
51.5%
Operating Margin
-11.33%
Profit Margin
-11%
Debt to Equity
10.64
Operating Cash Flow
N/A
Beta
0.47
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AIH Overview
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AIH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AIH ($0.97) is undervalued by 49.39% relative to our estimate of its Fair Value price of $1.92 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AIH ($0.97) is significantly undervalued by 49.39% relative to our estimate of its Fair Value price of $1.92 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
AIH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AIH due diligence checks available for Premium users.
Be the first to know about important AIH news, forecast changes, insider trades & much more!
AIH News
Valuation
AIH fair value
Fair Value of AIH stock based on Discounted Cash Flow (DCF)
Price
$0.97
Fair Value
$1.92
Undervalued by
49.60%
AIH ($0.97) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AIH ($0.97) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AIH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AIH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.58x
Industry
9.14x
Market
52.58x
AIH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.74x
Industry
4.65x
AIH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AIH's financial health
Profit margin
Revenue
$21.7M
Net Income
$70.0k
Profit Margin
0.3%
AIH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$94.2M
Liabilities
$87.8M
Debt to equity
10.64
AIH's short-term liabilities ($71.10M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AIH's short-term assets ($27.07M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AIH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
AIH vs Medical Care Facility Stocks
Aesthetic Medical International Holdings Group Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.